Gain Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $64 |
Gross Profit | -20 | -20 | 41 |
EBITDA | -8,162 | -4,371 | -4,396 |
EBIT | -8,182 | -4,391 | -4,419 |
Net Income | -8,143 | -4,014 | -4,723 |
Net Change In Cash | 0 | 0 | 64 |
Free Cash Flow | -5,777 | -3,586 | -5,660 |
Cash | 16,936 | 10,641 | 11,794 |
Basic Shares | 19,215 | 17,978 | 16,206 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $55 | $140 | $164 | $28 |
Gross Profit | -11,323 | 75 | -6,999 | -2,230 |
EBITDA | -22,169 | -17,777 | -13,822 | -3,469 |
EBIT | -22,253 | -17,841 | -13,837 | -3,479 |
Net Income | -22,267 | -17,590 | -13,890 | -3,577 |
Net Change In Cash | 55 | 140 | 164 | 28 |
Cost of Revenue | -29,545 | |||
Free Cash Flow | -18,881 | -14,811 | -12,459 | -3,261 |
Cash | 11,794 | 7,311 | 36,880 | 7,492 |
Basic Shares | 13,011 | 11,883 | 10,165 | 11,876 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.17 |
2024-06-30 | -$0.42 |
2024-03-31 | -$0.22 |
2023-12-31 | -$0.36 |
